Cargando...
Current approaches and advance in mantle cell lymphoma treatment
Mantle cell lymphoma (MCL) is a set of heterogeneous non-Hodgkin lymphoma characterized by involvement of lymph nodes, spleen, bone marrow and blood. Under conventional treatment, survival time is 4 to 5 years with short remission period and there is still no standard treatment for MCL. In general,...
Gardado en:
| Publicado en: | Stem Cell Investig |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923656/ https://ncbi.nlm.nih.gov/pubmed/27358886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2306-9759.2015.09.02 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|